Lacktman Discusses Joint Commission’s Decision to Hold Off on Proposed Changes to Telehealth Standards
October 11, 2017
Fierce Healthcare
Partner Nathaniel Lacktman was quoted in a Fierce Healthcare article, “Joint Commission Pulls Back Proposed Telehealth Standards,” covering the impact of the Joint Commission’s decision to not move forward with proposed changes that would have added new burdens to hospitals and ambulatory care clinics with telehealth programs. The proposal would have required hospitals providing direct-to-telehealth services to obtain informed consent from patients about the type of care and the modality used. The new standards were viewed by many as an additional burden.
“It’s really problematic for hospitals that spent a lot of time and resources and thoughtfulness in building out patient-centered innovative telehealth programs only to have a relatively esoteric Joint Commission standard come into effect and turn that all upside down,” Lacktman said.
But Lacktman said he also was pleased to see the Joint Commission back off the proposed standards and continue evaluating the feedback it had received. “I think that shows they are willing to listen to providers and hospitals in the telemedicine industry,” he said. “What that does mean is hospitals and telemedicine providers need to take time to submit comments or their feedback.”
“It’s really problematic for hospitals that spent a lot of time and resources and thoughtfulness in building out patient-centered innovative telehealth programs only to have a relatively esoteric Joint Commission standard come into effect and turn that all upside down,” Lacktman said.
But Lacktman said he also was pleased to see the Joint Commission back off the proposed standards and continue evaluating the feedback it had received. “I think that shows they are willing to listen to providers and hospitals in the telemedicine industry,” he said. “What that does mean is hospitals and telemedicine providers need to take time to submit comments or their feedback.”
People
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."
June 4, 2025
In the News
Foley Attorneys Explore IP Considerations for AI-Generated Logos
Foley & Lardner LLP attorneys Von Bryant, Norm Rich, and Alex Liederman authored the Bloomberg Law article, "AI-Generated Logos Require Careful Steps to Protect IP Rights."